Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: Double trouble?

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 6, 2015, Pages 763-765

  Broos, Caroline E ^a   Van Nimwegen, Menno ^a   In't Veen, Johannes C C M ^b   Hoogsteden, Henk C ^a   Hendriks, Rudi W ^a   Van Den Blink, Bernt ^a   Kool, Mirjam ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER; CTLA4 PROTEIN, HUMAN;

CD4+ T LYMPHOCYTE; HUMAN; LETTER; LUNG LAVAGE; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; METASTATIC MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SARCOIDOSIS; T LYMPHOCYTE ACTIVATION; TH17 CELL; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM;

BIOMARKERS; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; HUMANS; SARCOIDOSIS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84942279504     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201503-0635LE     Document Type: Letter

References (11)

1. Walker LS, Sansom DM. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 2011;11:852-863.
2. Tissot C, Carsin A, Freymond N, Pacheco Y, Devouassoux G. Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy. Eur Respir J 2013;41: 246-247.
3. Vogel WV, Guislain A, Kvistborg P, Schumacher TN, Haanen JB, Blank CU. Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission. J Clin Oncol 2012;30: e7-e10.
4. Broos CE, van Nimwegen M, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Granuloma formation in pulmonary sarcoidosis. Front Immunol 2013;4:437.
5. Ten Berge B, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN, Hendriks RW, Kleinjan A. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford) 2012;51:37-46.
6. Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, Bulashevska A, Petersen BS, Schäffer AA, Grüning BA, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014;20:1410-1416.
7. Ying H, Yang L, Qiao G, Li Z, Zhang L, Yin F, Xie D, Zhang J. Cutting edge: CTLA-4-B7 interaction suppresses Th17 cell differentiation. J Immunol 2010;185:1375-1378.
8. Oda K, Ishimoto H, Yatera K, Yamada S, Nakao H, Ogoshi T, Noguchi S, Yamasaki K, Kawanami T, Mukae H. Relationship between the ratios of CD4/CD8 T-lymphocytes in the bronchoalveolar lavage fluid and lymph nodes in patients with sarcoidosis. Respir Investig 2014;52: 179-183.
9. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002;3: 611-618.
10. Chain JL, Martin AK, Mack DG, Maier LA, Palmer BE, Fontenot AP. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation. J Immunol 2013;191:1648-1656.
11. Hattori N, Niimi T, Sato S, Achiwa H, Maeda H, Oguri T, Bessho Y, Ito H, Shimizu S, Ueda R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:27-32.